| Recruiting | A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regu Nephritis, Lupus, Lupus Erythematosus, Systemic | Phase 3 | 2026-02-09 |
| Completed | A Trial to Evaluate the Absolute Bioavailability of Cenerimod in Healthy Male Participants Healthy Subjects | Phase 1 | 2025-12-11 |
| Completed | A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Japanese and Caucasian Hea Healthy Volunteers | Phase 1 | 2025-10-07 |
| Enrolling By Invitation | Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus Lupus Erythematosus, Systemic | Phase 3 | 2024-07-30 |
| Active Not Recruiting | A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Er Lupus Erythematosus, Systemic | Phase 3 | 2023-06-26 |
| Recruiting | A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Lupus Erythematosus, Systemic | Phase 3 | 2022-12-13 |
| Completed | The Effect of Severe Kidney Impairment on Cenerimod Pharmacokinetics Healthy, Renal Impairment | Phase 1 | 2021-09-27 |
| Completed | A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of Cenerimod Healthy, Hepatic Impairment | Phase 1 | 2021-08-25 |
| Enrolling By Invitation | Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Acute Myocardial Infarction | Phase 3 | 2021-08-14 |
| Completed | A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy Subjects Healthy Subjects | Phase 1 | 2020-11-06 |
| Completed | The Effect of Reduced Liver Function on Selatogrel Pharmacokinetics Healthy Subjects, Hepatic Impairment | Phase 1 | 2020-07-22 |
| Completed | To Study the Effect of Cenerimod on the Electrical Activity of the Heart, in Men and Women. To Study the Effec Healthy Subjects | Phase 1 | 2020-01-31 |
| Completed | Single Oral Dose of 4 mg Cenerimod in Healthy Japanese and Caucasian Subjects Healthy Volunteers | Phase 1 | 2019-08-07 |
| Completed | A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy Subjects Healthy Subject | Phase 1 | 2019-01-03 |
| Completed | Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupu Systemic Lupus Erythematosus | Phase 2 | 2018-12-21 |
| Completed | A Study to Evaluate ACT-246475 Fate in Healthy Male Subjects Healthy Subjects | Phase 1 | 2018-07-27 |
| Completed | A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Heart Attack Acute Myocardial Infarction | Phase 2 | 2018-07-10 |
| Completed | A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Health Healthy | Phase 1 | 2018-01-24 |
| Completed | A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease Stable Coronary Artery Disease | Phase 2 | 2018-01-24 |
| Completed | A Study Conducted in Healthy Male Subjects to Investigate the Safety and Tolerability of AC-76, Its Fate in th Healthy Subjects | Phase 1 | 2016-11-29 |
| Completed | A Study to Evaluate Cenerimod in Healthy Male Subjects Healthy Subjects | Phase 1 | 2016-09-01 |
| Completed | Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-33444 Systemic Lupus Erythematosus | Phase 1 / Phase 2 | 2015-06-01 |
| Terminated | Clinical Study to Investigate Safety and Effects on Heart Rate, Blood Pressure, and Pharmacokinetic Interactio Healthy Subjects | Phase 1 | 2015-04-28 |